UDI - ETF AI Analysis
Top Page
USCF Dividend Income Fund (UDI)
UDI, the USCF Dividend Income Fund, has a solid overall rating, reflecting a portfolio anchored by strong, cash-generating companies like Verizon, Canadian Natural, Medtronic, and Johnson & Johnson that combine healthy financial performance, dividends, and generally positive outlooks. These strengths are slightly tempered by holdings such as AbbVie and Lamar Advertising, where higher leverage, valuation concerns, or financial stability issues introduce some risk, and by exposure to energy names like Phillips 66 and ConocoPhillips, which can add sector-related volatility.
UDI vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.14M
- Region
- North America
- Expense Ratio
- 0.65%
- Beta
- 0.51
- Issuer
- USCF Advisers
- Inception Date
- Jun 08, 2022
- Dividend Yield
- 2.62%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
UDI Summary
The USCF Dividend Income Fund (UDI) is an ETF that focuses on dividend-paying stocks across the U.S. and Canadian markets, without tracking a specific index. It spreads investments across many sectors, including financials, health care, energy, and technology. Well-known companies in the fund include Johnson & Johnson and AbbVie. Someone might invest in UDI to seek a mix of income from dividends and long-term growth, while staying diversified across different industries. A key risk is that stock prices and dividend payments can go up or down with the overall market, so returns are not guaranteed.
How much will it cost me?
This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s more actively managed with a specialized focus on dividend income rather than simply tracking a broad market index.
What would affect this ETF?
This U.S.-focused dividend ETF could benefit if the economy stays stable, interest rates eventually ease, and sectors like financials, health care, and energy continue to support strong company profits and reliable dividend payments from holdings such as AbbVie, Johnson & Johnson, and Phillips 66. On the downside, higher-for-longer interest rates, tighter banking regulations, pressure on energy companies, or a broad market downturn could hurt both dividend payouts and share prices, especially given its sizable exposure to financials, real estate, and utilities.
UDI Top 10 Holdings
UDI leans heavily on dividend-rich financials and energy names, with State Street, East West Bancorp, Phillips 66, ConocoPhillips, and Canadian Natural doing much of the heavy lifting. Phillips 66, in particular, has been a strong engine for recent gains, while AbbVie and Johnson & Johnson add steady health care ballast with rising share prices and reliable income. On the flip side, Lamar Advertising and Verizon have been lagging, dulling some of that momentum. The fund is largely U.S.-focused, with a dash of Canadian energy, and shows a clear tilt toward income-heavy value sectors over flashy growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | 3.67% | $114.48K | $646.92B | 41.21% | 78Outperform |
 ABBV | AbbVie | 3.56% | $111.12K | $506.08B | 25.59% | 66Neutral |
 MDT | Medtronic | 3.46% | $107.95K | $120.18B | -0.19% | 80Outperform |
 EWBC | East West Bancorp | 3.45% | $107.76K | $18.00B | 27.87% | 79Outperform |
 COP | Conocophillips | 3.27% | $102.09K | $177.75B | 66.83% | 78Outperform |
 PSX | Phillips 66 | 3.14% | $98.01K | $107.15B | 98.29% | 73Outperform |
 TSE:CNQ | Canadian Natural | 3.11% | $97.22K | CAD 156.57B | 72.18% | 81Outperform |
 LAMR | Lamar Advertising | 3.14% | $98.13K | $15.74B | 29.16% | 72Outperform |
 STT | State Street | 2.77% | $86.47K | $46.62B | 46.02% | 75Outperform |
 PAYX | Paychex | 2.48% | $77.57K | $38.89B | -12.60% | 77Outperform |
UDI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For UDI, the sentiment is Positive. The current price of 36.73 is above the 20-day moving average (MA) of 35.96, above the 50-day MA of 36.38, and above the 200-day MA of 34.85, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 60.73 is Neutral, neither overbought nor oversold. The STOCH value of 76.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UDI.
UDI Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| UDI | $36.74 | $40.00(8.89% Upside) | $3.14M | 0.65% | 72Outperform |
 STNC | $36.91 | $42.51(15.18% Upside) | $92.30M | 0.85% | 68Neutral |
 SOVF | $31.96 | $37.70(17.96% Upside) | $91.03M | 0.75% | 70Neutral |
 PFOE | $22.21 | $28.79(29.60% Upside) | $88.59M | 0.59% | 75Outperform |
 VAMO | $36.07 | $42.11(16.73% Upside) | $87.83M | 0.65% | 63Neutral |
 YALL | $43.04 | $53.31(23.85% Upside) | $80.10M | 0.65% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| UDI | USCF Dividend Income Fund | 36.73 | 7.25 | 24.59% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 36.91 | 3.93 | 11.92% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.96 | 2.92 | 10.05% | |
| PFOE | Pathfinder Focused Opportunities ETF | 22.21 | -2.64 | -10.63% | |
| VAMO | Cambria Value & Momentum ETF | 36.07 | 3.50 | 10.75% | |
| YALL | God Bless America ETF | 43.04 | -2.04 | -4.53% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.